CAH - Cardinal Health, Inc.
| Previous Close | 54.81 |
| Open | 54.46 |
| Bid | 52.11 x 800 |
| Ask | 55.69 x 1000 |
| Day's Range | 53.78 - 55.44 |
| 52 Week Range | 48.14 - 75.75 |
| Volume | 4,184,723 |
| Avg. Volume | 3,695,376 |
| Market Cap | 16.062B |
| Beta (3Y Monthly) | 1.24 |
| PE Ratio (TTM) | 22.90 |
| EPS (TTM) | 2.35 |
| Earnings Date | Feb 6, 2019 - Feb 11, 2019 |
| Forward Dividend & Yield | 1.91 (3.48%) |
| Ex-Dividend Date | 2018-12-31 |
| 1y Target Est | 56.29 |
- Insider Monkey•2 days ago
Do Hedge Funds Love Cardinal Health, Inc. (CAH)?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth depends on it. Regardless of the various methods used by elite investors like David Tepper and Dan Loeb, […]
- Zacks•2 days ago
Cardinal (CAH) Down 4% Since Last Earnings Report: Can It Rebound?
Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Markit•3 days agoSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
- PR Newswire•3 days ago
Cardinal Health Elects J. Michael Losh to its Board of Directors
DUBLIN, Ohio, Dec. 7, 2018 /PRNewswire/ -- Cardinal Health (CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit Committee.
- PR Newswire•10 days ago
Research Explores the Issues Impacting Today's Oncology Practices
DUBLIN, Ohio, Nov. 30, 2018 /PRNewswire/ -- Oncologists are growing more confident in their ability to meet the requirements of the Medicare Access & CHIP Reauthorization Act (MACRA), according to new research from Cardinal Health Specialty Solutions. Request a copy of the Oncology Insights report at www.cardinalhealth.com/oncologyinsights. The report compares current views about MACRA to responses collected in early 2017, shortly after MACRA went into effect.
Markit•11 days agoSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
- Zacks•12 days ago
Is Cardinal Health (CAH) a Great Stock for Value Investors?
Let's see if Cardinal Health (CAH) stock is a good choice for value-oriented investors right now from multiple angles.
- Zacks•12 days ago
Cardinal Health to Highlight Cost-Control Approach in ASHP
Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.
- PR Newswire•13 days ago
Drug cost containment strategies for hospital pharmacy leaders highlighted at ASHP Midyear
Cardinal Health introduces approach to address sustainable cost control DUBLIN, Ohio , Nov. 27, 2018 /PRNewswire/ -- At the 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, ...
- Morningstar•14 days ago
Cardinal's a Critical Link in the Pharma Supply Chain
The drug distributor is able to turn its significant size and market share into key competitive advantages. Cardinal is an important cog in the pharmaceutical industry, as many supply-chain participants depend on its services for streamlined product distribution and procurement. Cardinal is the third-largest pharmaceutical distributor by revenue and is the main supplier to CVS Health's retail pharmacy network.
- Thomson Reuters StreetEvents•19 days ago
Edited Transcript of CAH earnings conference call or presentation 8-Nov-18 1:30pm GMT
Q1 2019 Cardinal Health Inc Earnings Call
- Simply Wall St.•25 days ago
What Should We Expect From Cardinal Health Inc’s (NYSE:CAH) Earnings In The Year Ahead?
Based on Cardinal Health Inc’s (NYSE:CAH) earnings update on 30 September 2018, analysts seem highly optimistic, with earnings expected to grow by a high double-digit of 83% in the upcoming Read More...
Markit•last monthSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
- American City Business Journals•last month
Cardinal Health finally sees savings from the tax cut – here's how it's spending it
Cardinal Health Inc. is putting federal tax savings and proceeds of a partial divestiture into more share buybacks and capital investments, while continuing cost-cutting measures.
- TheStreet.com•last month
Cardinal Health Stock Has Formed a Bullish Reversal Pattern
The CAH chart, below, shows the stock price had been in a consistent downtrend from January of this year, making a series of lower lows and lower highs. The market selloff in October resulted in CAH successfully testing its $50.00 support level. Given that CAH had previously violated its downtrend, based for approximately six months and has now violated long-standing resistance with respectable volume, we believe it has formed a bullish reversal pattern.
Motley Fool•last monthCardinal Health Inc (CAH) Q1 2019 Earnings Conference Call Transcript
CAH earnings call for the period ending September 30, 2018.
- Zacks•last month
Cardinal Health (CAH) Surpasses Earnings Estimates in Q1
Cardinal Health (CAH) Q1 results benefit from strong sales in the Pharmaceutical and the Medical segments.
- Zacks•last month
Cardinal Health (CAH) Beats on Earnings & Revenues in Q1
Cardinal Health's (CAH) solid segmental performance buoys optimism. FY19 view reiterated.
Markit•last monthSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
- The Wall Street Journal•last month
[$$] Cardinal Health 1Q Profit Surges
Cardinal Health posted a more than fivefold surge in first-quarter profit, led by growth in its pharmaceuticals business despite generic drug competition pressures.
- MarketWatch•last month
Cardinal Health's stock surges after earnings, revenue rise above expectations
Shares of Cardinal Health Inc. rallied 2.9% in premarket trade Thursday after the healthcare services company reported fiscal first-quarter profit and revenue that rose above expectations, boosted by strength in its pharmaceuticals business. Net income rose to $593 million, or $1.94 a share, from $115 million, or 36 cents a share, in the same period a year ago, with the naviHealth divestiture resulting in a gain of $503 million. Excluding non-recurring items, adjusted earnings per share came to $1.29, above the FactSet consensus of $1.08. Revenue increased 8% to $35.2 billion, beating the FactSet consensus of $33.7 billion. Pharmaceutical segment revenue grew 9% to $31.4 billion, well above the FactSet consensus of $29.8 billion. The company affirmed its 2019 adjusted EPS outlook of $4.90 to $5.15, which surrounds the FactSet consensus of $4.99. The stock has rallied 9.6% over the past three months through Wednesday, while the SPDR Health Care Select Sector ETF has gained 3.4% and the S&P 500 has slipped 1.5%.
- Associated Press•last month
Cardinal: Fiscal 1Q Earnings Snapshot
On a per-share basis, the Dublin, Ohio-based company said it had net income of $1.94. Earnings, adjusted for one-time gains and costs, were $1.29 per share. The results topped Wall Street expectations. ...
- PR Newswire•last month
Cardinal Health Reports First Quarter Results for Fiscal Year 2019
- Revenue increased 8 percent to $35.2 billion - GAAP(1) operating earnings increased 211 percent to $816 million , including a $508 million gain on sale of naviHealth; non-GAAP operating earnings decreased ...
- Motley Fool•last month
3 Top Dividend Stocks to Buy Right Now
These high-yield stocks deserve a place in your portfolio.
